Vision Improvement for Patients With Age-Related Macular Degeneration
ConditionMacular Degeneration
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-100
SponsorVIS, Inc.
About this trial
This study is being conducted to assess the safety and efficacy of the VIS, LLC (VIS) Opti-K Low Vision Aid Device and treatment to provide vision improvement to patients with age-related macular degeneration.
Eligibility criteria
Qualifiers
Male or Female
Any race
Patient is at least 50 years old.
Patient has diagnosed end stage dry or wet age-related macular degeneration in one or both eyes, as verified by a complete ocular examination.
Disqualifiers
Corneal disease or corneal disorder in either eye.
Pathological retinal morphology in either eye that completely affects the entire 10° (3 mm diameter) of the retina centered on the foveola.
Gonzalez-Markowitz chart Potential Visual Acuity (PVA) in the eye to be treated that is not improved by at least four lines compared to CDVA;
Increased IOP (above 20 mm Hg), glaucoma or history of glaucoma;
Trial design
Treatments tested in this trial
- Vision Improvement
Treatment groups
200 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov